2013, November 21
D-Pharm starts Phase 2 clinical study with DP-b99 in acute high-risk pancreatitis patients
2013, November 13
The company has called for an annual and extraordinary general meeting on December 4, 2013.
2013, October 30
D-Pharm granted patent in US and China for its Phase II product THR-18.
Therapeutic Focus & Market Size
Reports & Regulatory Announcements
Presentation & Factsheet
Advisors & Investors Contacts